Fin301  group ii-- the drug scene
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Fin301 group ii-- the drug scene

on

  • 664 views

 

Statistics

Views

Total Views
664
Views on SlideShare
664
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Fin301 group ii-- the drug scene Presentation Transcript

  • 1. FIN30 Ms. Mahtab Faruqui
  • 2. Group II~~ ~~~Section 03 Lamisa Manzoor 11304072  Protiti Khan 11304018  Upeksha Abeysekara 11204098  Fariha Ahmed 11204035  Samiya Yesmin 11304043 
  • 3. BEXIMCO Pharmaceuticals Ltd. (BPL)     BPL was founded in 1976 and started operations in 1980 It started exporting in 1992 It is the largest pharmaceutical exporter, to over 45 countries. BPL is the only company to win National Export Trophy (Gold) Square Pharmaceuticals Ltd. (SPL)     SPL was established in 1958 and went public 1991 Mr. Samson H. Chowdhury is the founder SPL is Bangladesh’s largest pharmaceutical It has been continuously in the 1st position among all national and multinational companies since 1985.
  • 4. Industrial Outlook  OPPORTUNITIES:  Advancing technologically  Research and development  Export opportunities have increased  Low operational costs  Government benefits  THREATS:  Indian companies  Bangladeshi government does not have the right policy  Small and new firms  Large scale manufacturers from multinational companies  Neighboring countries may enter our market illegally  In the long run there might be shortage of raw materials  Fluctuations in raw material prices
  • 5. 2. Acid-Test/ Quick Ratio 1. Current Ratios 3 2 Quick Ratio= Current Assets— Inventories Current Liabilities 2.5 2 Ratio Ratio 1.5 1 0.5 0 2010 2011 2012 2 1.8 1.6 1.4 1.2 1 0.8 0.6 0.4 0.2 0 Years 1 Current Ratio= Current Assets Current Liabilities 2010 BPL SPL 2011 2012 Years
  • 6. 4. Debt-to-Total Assets Ratio 3. Debt-to Equity Ratio 0.45 4 Debt-To-TotalAssets= Total Debt Total Assets Ratio 0.4 BPL 0.35 SPL 0.35 0.3 0.3 0.25 0.25 Ratio 0.2 0.15 0.2 0.1 0.15 0.05 0.1 0 2010 3 Debt-To-Equity= 2011 2012 Years Total Debt Shareholders’ Equity 0.05 0 2010 2011 2012 Years
  • 7. 6. Receivables Turnover Ratio 5. Interest Coverage Ratio 12 Receivable Turnover (RT)= 6 10 BPL 8 Annual Net Credit Sales Receivables SPL Ratio Ratio 25 6 20 4 15 2 10 0 2010 2011 Years 2012 5 0 5 Interest Coverage= EBIT Interest Expense 2010 2011 2012 Years
  • 8. 50 45 40 35 30 25 20 15 10 5 0 8 Inventory Turnover (IT)= BPL Cost Of Goods Sold Inventory SPL 2.5 2 1.5 1 2010 7 8. Inventory Turnover Ratio Ratio Ratio 7. Receivables Turnover in Days Ratio 2011 Receivable Turnover In Days (RTD) = 2012 Years 365 RT 0.5 0 2010 2011Years 2012
  • 9. 9. Inventory Turnover in Days Ratio 10. Asset Turnover Ratio 350 10 Asset Turnover= 300 250 BPL Net Sales Total Assets SPL 0.8 Ratio 200 Ratio 150 100 0.7 0.6 0.5 50 0.4 0 2010 2011 2012 0.3 0.2 Years 0.1 9 Inventory Turnover In Days (ITD)= 365 IT 0 2010 2011 Years 2012
  • 10. 11. Net Profit Margin Ratio 20 18 Net Profit After Taxes 16 11 Net Profit Margin= Net Sales 14 Ratio 12 10 BP L 8 6 4 2 0 2010 2011 2012 Years
  • 11. 12. Return on Investment Ratio 13. Return on Equity Ratio 25 1 2 Return On Investment (ROI)= Net Profit After Taxes Total Assets 20 16 15 Ratio 14 12 10 Ratio 10 5 8 6 0 4 2010 2 2011Years 2012 0 2010 2011 Years 13 2012 BPL Return On Equity (ROE)= Net Profit After Taxes Shareholders’ Equity
  • 12. Sector Market Analysis     SPL≈tk.240 BPL≈ tk. 52 Price: SPL is x5 BPL Share Volume: SPL is double of BPL
  • 13. Conclusion  SPL:  higher  performance  higher market share  higher profitability  lower liquidity than BPL  lower risk  BPL: smaller market share  lower profitability  higher risk  greater liquidity than SPL.  Defensive Investment βSPL:0.53 < βBPL:0.88
  • 14. Recommendations     SPL needs to increase liquidity. Benchmarking for BPL. Research & Development for increased growth. Both companies need to look for new market segments.
  • 15. Questions? ~The End~